
Investing.com - Cryoport plunged in after-hours Wednesday after the logistics solutions provider cut its annual guidance as weaker demand and clinical trial delays weighed on growth.
Cryoport (NASDAQ:CYRX) fell 24% in after-hours trading following the report.
The company said it now expects annual revenue in a range of $233 million to $243M, down from a prior range of $270M to $290M.
The weaker outlook comes as the company estimated second-quarter revenue to be between $56.5M and $57.5M for the second quarter of 2023. That was short of Wall Street estimates of $67M, with the company flagging several factors that pressured growth including “weaker than expected global demand for capital equipment; clinical trial start delays; and slower than expected ramps from certain clients."
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.